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Abstract: Effect of oral administration of “Gadagi” tea on lipid profile was assessed in 50 healthy male albino rats 
which were grouped and administered with different doses(mg/kg) i.e low dose (380mg/kg, 415mg/kg, 365mg/kg, 
315mg/kg  for “sak”, ”sada” and “magani” respectively), standard dose (760mg/kg, 830mg/kg, 730mg/kg for “sak’, 
”sada” and “magani” respectively) and high dose ( 1500mg/kg, 1700mg/kg and 1460mg/kg for “sak’’, ”sada” and 
“magani” groups respectively) for a period of four weeks. Animals that were not administered with the tea constituted 
the control group. At the end of fourth week, the animals were sacrificed and their serum Total Cholesterol (T. Chol), 
HDL–Cholesterol (HDL Chol), Triglyceride (TRIG), very low – density lipoproteins (VLDL) and Low Density 
Lipoproteins (LDL) levels were determined. Although no significant difference(P<0.05) was found between the 
experimental groups and the control group using analysis of variance (ANOVA), mean serum LDL, T. Chol and TRIG  
levels were slightly lower in rats  orally administered with “magani” at standard dose level than that of the control rats. 
Thus, it could be suggested that “magani” especially at standard dose could reduce some of the risk factors of 
cardiovascular disease. 
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INTRODUCTION 
A lipid profile, also known as lipid panel or coronary risk 
panel, measures serum total cholesterol, HDL 
cholesterol, LDL–cholesterol and triglyceride. 
Cholesterol is doubtless the most publicized lipid, 
notorious, because of the strong correlation between 
high levels of cholesterol in the blood and the incidence 
of human cardiovascular disease (David and Michael, 
2008). Epidemiological study (Henry et al., 2003; 
Gordon et al., 2002) has shown that, the level of total 
serum cholesterol is a strong predictor of the likelihood 
that an individual will develop heart disease and to a 
much lesser degree, stroke. However, elevated levels 
of the lipoprotein fractions, LDL and VLDL, are 
regarded as artherogenic and prone to cause 
artherosclerosis, and levels of these fractions rather 
than the total cholesterol levels correlate with the extent 
and progress of artherosclerosis (Brunzell et al., 2008). 
According to lipid hypothesis, abnormally high 
cholesterol levels (hypercholesterolemia), that is higher 
concentration of LDL and lower concentration of HDL, 
are strongly associated with cardiovascular diseases 
because these promote atheroma development in 
arteries (atherosclerosis). There is increasing evidence 
that intake of sour tea (Hibiscus sabdariffa) has 
hypoglycemic and hypolipidemic effects (Muzaffar-
Khosravi et al., 2009) 
 
“Gadagi” tea is a special type of tea prepared and sold 
to various people engaged in strenuous jobs to achieve 
different purposes, such as stimulation, medication, 
agitation and total ability to endure any hardship 
involved in goal attainments. It is a concoction of 
several herbs and shrubs, which is believed to posses 
so many medicinal values by the users. All herbs 
contain substances that may cause undesirable side 
effects or interact with medication (Gadanya, 2011). 
The composition of the 3 major types of “Gadagi” tea, 
viz: "Sak","sada" and "magani" has been reported 
previously (Gadanya et al., 2011). 
 
There is a high rate of consumption of “Gadagi” tea in 
Kano and some other parts of northern Nigeria 
(Gadanya, 2011). There is the need to assess the 
linkage between the consumption of the tea and 
incidence of cardiovascular diseases. Therefore, the 
research work reported in this paper was aimed at 
finding out the the effect of “Gadagi” tea consumption 
on lipid profile. 
 
MATERIALS AND METHODS 
Dose Selection and Preparation 
Samples of “sak”, “sada” and “magani” types of Gadagi” 
tea were obtained from Kofar Wambai Market, Kano, 
Nigeria (one of the oldest and the most popular 
“Gadagi” tea market). They were subjected to direct 
heating process. Residues were obtained and weighed 
using a weighing balance. The standard dose 
(760mg/kg, 830mg/kg, 730mg/kg, for “sak’, ”sada” and 
“magani” respectively) was prepared in 1cm3 of solvent 
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whereas the low dose (380mg/kg, 415mg/kg, 
365mg/kg, 315mg/kg  for “sak”, ”sada” and “magani” 
respectively) was prepared in 0.5cm3 of solvent and  
high dose (1500mg/kg, 1700mg/kg and 1460mg/kg for 
“sak’’, ”sada” and “magani” groups respectively) was 
prepared in 2 cm3 of solvent (Gadanya et al., 2011). 
. 
Experimental Design 
Fifty (50) experimental male albino rats were divided 
into four groups based on the type of “Gadagi” tea i.e. 
one control group and three experimental groups (for 
the three types of “Gadagi” tea). The control group 
consisted of five rats while the other three groups were 
further divided into three equal sub – groups each 
consisting of five rats. The three sub groups were for 
Standard dose (760mg/kg,830mg/kg,730mg/kg 
for“sak’,”sada”and “magani” respectively); Lowdose 
(380mg/kg, 415mg/kg, 365mg/kg, 315mg/kg  for “sak”, 
”sada” and “magani” respectively) and  high dose 
(1500mg/kg, 1700mg/kg and 1460mg/kg for “sak’’, 
”sada” and “magani” groups respectively).They were 
administered the doses of the tea orally using syringe 
once daily for a period of four weeks. At the fourth 
week, all the rats were sacrificed. Blood samples were 
collected and centrifuged to obtain sera for lipid profile 
analysis.  
 
Methods of Analysis  
Serum triglycerides (TRIG), very Low density 
lipoprotein (VLDL) and total cholesterol (T. Chol) levels 
were measured using the method of Carl and Edward 
(1983).Determination of serum high density lipoprotein 
(HDL-Chol) fraction was carried out using Lopes-Virella 
(1977) method, and serum low density lipoprotein (LDL) 
level was estimated using Friedwald et al., (1972) 
formula. 
 
Data collected were subjected to Analysis of variance 
(ANOVA) using the General Linear Model (SPSS for 
Windows). 
 
RESULTS AND DISCUSSION  
Serum total cholesterol (T. Chol), HDL-Cholesterol 
(HDL- Chol), Triglycerides (Trig), low density lipoprotein 
(LDL) and very low density lipoprotein (VLDL) levels of 
albino rats administered orally with “sak”, “sada” and 
“magani” for 4 weeks are presented in Tables 1-3. The 
mean T.Chol, HDL – Chol, Trig and VLDL levels of all 
the experimental rats in the different experimental 
groups of “sak” (Table 1), “sada”(Table 2) and 
“magani”(Table 2) were lower than those of the control 
group. No significant difference was found between the 
experimental groups and the control group using 
analysis of variance (ANOVA). However, a slight 
decrease in mean serum total cholesterol level was 
found in rats administered orally with “sak” at standard 
and at high dose levels, “sada” at low dose level and 
“magani” at low and standard dose levels. This could 
probably be attributed to the level of tannins present in 
the tea (Gadanya, 2011) which have been reported to 
have cholesterol lowering property (Shiavone et al., 
2008). Diets containing tannins at low dosages (0.15 – 
0.2%) may improve well being (Shiavone et al., 2008). 
Mean serum HDL-cholesterol level of rats orally 
administered with “sak” (Table 1) at low and standard 
dose levels, “sada” (Table 2) at low dose level and, 
“magani” (Table 3) at low and standard dose levels was 
significantly lower (P<0.05) than that of the control rats. 
Lower serum HDL-cholesterol level is not beneficial to 
health, in view of the reported negative association 
between HDL-cholesterol levels and cardiovascular 
disease (Kerver et al., 2003). 
 
Mean serum triglyceride level was slightly lower than 
that of the control rats at all the tested dose levels of 
“sak”, “sada” and “magani”. Mean serum VLDL level of 
the experimental rats was lower than that of the control 
rats. Reduced serum triglyceride level is an indication of 
utilization of either stored fats or triglyceride in 
circulating VLDL for energy purposes (Kerver et al., 
2003). 
 
 Mean LDL level was significantly lower (P<0.05) at 
standard dose level of “magani” (using t-test). Reduced 
LDL level is beneficial to the health, in view of the 
reported positive association between LDL-cholesterol 
levels and cardiorvascular disease (Kerver et al., 2003). 
From the results, although no significantly difference 
was found using ANOVA, the mean serum LDL and 
total cholesterol levels were slightly lower at standard 
dose level of “magani” than that of the control group, it 
could be suggested that, “magani” could probably 
reduce some of the risk factors of cardiovascular 
disease at standard dose level. The decreased HDL-
cholesterol level could be associated with increased 
risk of cardiovascular disease but only when there is 
increased LDL-cholesterol level, which was not the 
case following the administration of the tea. 
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Table 1: Serum Lipid Profile of albino rats orally administered “Sak” for four (4) weeks.  












Control  - 2.19 ± 0.31 0.74 ± 0.14 1.95 ± 0.51 0.89 ± 0.23 0.56 ± 0.26 
Low Dose  380 1.98 ± 0.31 0.60 ± 0.16 1.40 ± 0.16 0.64 ± 0.08 0.75 ± 0.42 
Standard Dose 760 1.81 ± 0.22 0.62 ± 0.71 1.47 ± 1.90 0.67 ± 0.86 0.52 ± 1.51 
High Dose  1520 1.78 ± 0.28 0.64 ± 0.11 1.62 ± 0.15 0.74 ± 0.66 0.40 ± 0.24 




Table 2: Serum lipid profile of albino rats orally administered “Sada” for four (4) weeks.  












Control  - 2.19 ± 0.31 0.74 ± 0.14 1.95 ± 0.51 0.89 ± 0.23 0.56 ± 0.26 
Low Dose  435 1.61 ± 0.27 0.47 ± 0.09 1.39 ± 0.17 0.63 ± 0.80 0.50 ± 0.20 
Standard Dose 870 0.21 ± 0.01 0.64 ± 0.19 1.47 ± 1.59 0.67 ± 0.75 0.79 ± 1.20 
High Dose  1740 2.11 ± 0.27 0.72 ± 0.74 1.57 ± 0.22 0.71 ± 0.10 0.68 ± 0.25 




Table 3: Serum lipid profile of albino rats orally administered “Magani” for four (4) weeks.  










Control  - 2.19 ± 0.31 0.74 ± 0.14 1.95 ± 0.51 0.89 ± 0.23 0.56 ± 0.26 
Low Dose  365 1.65 ± 0.00 0.43 ± 0.45 1.30 ± 0.12 0.59 ± 0.51 0.63 ± 0.32 
Standard Dose 730 1.53 ± 0.11 0.58 ± 0.05 1.53 ± 1.13 0.70 ± 0.06 0.25 ± 0.04 
High Dose  1460 2.11 ± 0.17 0.62 ± 0.07 1.51 ± 0.12 0.69 ± 0.57 0.80 ± 0.14 
Values are mean ± standard deviation (n =3).    
T. Chol  = Total cholesterol;   
HDL = High Density Lipoproteins;  
Trig = Triglycerides;  
VLDL = Very Low Density Lipoprotein  
LDL = Low Density Lipoproteins 
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